Saturday, July 11, 2026

pharma · HIV Infections · Infection, Human Immunodeficiency Virus

ViiV Healthcare

ViiV Healthcare is a pharma organization headquartered in London, GB. Primary therapeutic focus areas include HIV Infections, Infection, Human Immunodeficiency Virus. NovaPharmaNews links 3 clinical program(s), 0 drug pr

London, GB HQ
2009 Founded
1,906 Employees
EMA registrant Type
Company details
Status
Public
HQ
London, GB
Founded
2009
Employees
1,906
Programs
3
Drugs
5
Patents
0
Clinical program

BMS-955176

Phase 2 · small molecule · HIV Infections

BMS-955176 for HIV Infections is a Phase 2 program (small_molecule) at ViiV Healthcare B.V. with 1 ClinicalTrials.gov record(s).

← All ViiV Healthcare B.V. projects Phase 2 small molecule terminated

Internal code 205892

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
ViiV Healthcare B.V.
Phase
Phase 2
Modality
small_molecule
Indication
HIV Infections
Status
terminated
Trials
1

Clinical trials